This is a summary of the European public assessment report (EPAR) for Savene. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Savene.
Therapeutic Indication
### Therapeutic indication Savene is indicated for the treatment of anthracycline extravasation.
Therapeutic Area (MeSH)
N/AATC Code
V03AF02
ATC Item
dexrazoxane
Pharmacotherapeutic Group
All other therapeutic products
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| dexrazoxane hydrochloride | N/A | 右雷佐生 |
EMA Name
Savene
Medicine Name
Savene
Aliases
N/ANo risk management plan link.
